{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T06:44:50Z","timestamp":1793256290710,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000030","name":"CDC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.vaccine.2018.11.043","type":"journal-article","created":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T07:00:06Z","timestamp":1542870006000},"page":"56-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Impact of implementing a technology platform in community pharmacies to increase adult immunizations rates"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5350-2643","authenticated-orcid":false,"given":"Nizar K.","family":"Wehbi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2422-7758","authenticated-orcid":false,"given":"Rajvi J.","family":"Wani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald G.","family":"Klepser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice","family":"Murry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali S.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.11.043_b0005","unstructured":"Rolfes MA, Foppa IM, Garg S, Flannery B, Brammer L, Singleton JA, et al. Estimated influenza illnesses, medical visits, hospitalizations, and deaths averted by vaccination in the United States. Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases (NCIRD) 2016;December 9."},{"key":"10.1016\/j.vaccine.2018.11.043_b0010","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1080\/21645515.2016.1215393","article-title":"Community pharmacies as sites of adult vaccination: a systematic review","volume":"12","author":"Burson","year":"2016","journal-title":"Hum Vaccin Immunotherap"},{"key":"10.1016\/j.vaccine.2018.11.043_b0015","unstructured":"National Committee for Quality Assurance. Improving Quality and Patient Experience. The State of Health Care Quality 2013; 2013."},{"key":"10.1016\/j.vaccine.2018.11.043_b0020","unstructured":"AdolescentVaccination.org. 10 Reasons to be Vaccinated. National Foundation for Infectious Diseases 2013. http:\/\/adolescentvaccination.org\/10-reasons [December 7, 2017]."},{"key":"10.1016\/j.vaccine.2018.11.043_b0025","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s10935-015-0394-3","article-title":"Estimated human and economic burden of four major adult vaccine-preventable diseases in the United States, 2013","volume":"36","author":"McLaughlin","year":"2015","journal-title":"J Primary Prevent"},{"key":"10.1016\/j.vaccine.2018.11.043_b0030","first-page":"95","article-title":"Vaccination coverage among adults, excluding influenza vaccination \u2013 United States, 2013","volume":"64","author":"Williams","year":"2015","journal-title":"MMWR Morb Mort Week Rep"},{"key":"10.1016\/j.vaccine.2018.11.043_b0035","unstructured":"Tomczyk S, Bennett NM, Stoecker C, Gierke R, Moore MR. Use of 13-Valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged \u2265 65 years\u202f: recommendations of the advisory committee on immunization practices (ACIP) 2014;63:822\u20136."},{"key":"10.1016\/j.vaccine.2018.11.043_b0040","first-page":"95","article-title":"Noninfluenza vaccination coverage among adults \u2014 United States, 2012","volume":"63","author":"Williams","year":"2014","journal-title":"Morb Mort Week Rep (MMWR)"},{"key":"10.1016\/j.vaccine.2018.11.043_b0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6501a1","article-title":"Surveillance of vaccination coverage among adult populations \u2014 United States, 2014","volume":"65","author":"Williams","year":"2016","journal-title":"MMWR Surveill Summaries"},{"key":"10.1016\/j.vaccine.2018.11.043_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2008.05.005","article-title":"Barriers to adult immunization","volume":"121","author":"Johnson","year":"2008","journal-title":"Am J Med"},{"key":"10.1016\/j.vaccine.2018.11.043_b0055","doi-asserted-by":"crossref","first-page":"5708","DOI":"10.1016\/j.vaccine.2016.08.085","article-title":"Impact of pharmacists as immunizers on vaccination rates: a systematic review and meta-analysis","volume":"34","author":"Isenor","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.11.043_b0060","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.1016\/j.vaccine.2009.04.055","article-title":"Alternative vaccination locations: who uses them and can they increase flu vaccination rates?","volume":"27","author":"Lee","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.11.043_b0065","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1478-7547-10-10","article-title":"Planning influenza vaccination programs: a cost benefit model","volume":"10","author":"Duncan","year":"2012","journal-title":"Cost Effective Resour Allocat"},{"key":"10.1016\/j.vaccine.2018.11.043_b0070","first-page":"570","article-title":"Implementation of a community pharmacy-based influenza vaccination program","volume":"37","author":"Ernst","year":"1997","journal-title":"J Am Pharm Assoc"},{"key":"10.1016\/j.vaccine.2018.11.043_b0075","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/00005650-200104000-00005","article-title":"Effect of vaccination by community pharmacists among adult prescription recipients","volume":"39","author":"Grabenstein","year":"2001","journal-title":"Med Care"},{"key":"10.1016\/j.vaccine.2018.11.043_b0080","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1331\/JAPhA.2013.12019","article-title":"Effect of pharmacist intervention on herpes zoster vaccination in community pharmacies","volume":"53","author":"Wang","year":"2013","journal-title":"J Am Pharm Assoc"},{"key":"10.1016\/j.vaccine.2018.11.043_b0085","unstructured":"Kennedy ED, Santibanez TA, Bridges CB, Singleton JA. March Flu vaccination coverage. United States, 2011\u20132012 influenza season; 2012."},{"key":"10.1016\/j.vaccine.2018.11.043_b0090","unstructured":"National Association Chain Drug Stores. Community pharmacy fills gaps in access and affordability for patients, payers; 2014."},{"key":"10.1016\/j.vaccine.2018.11.043_b0095","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMp068155","article-title":"Primary care \u2014 will it survive?","volume":"355","author":"Bodenheimer","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2018.11.043_b0100","first-page":"1","article-title":"Adult immunization programs in nontraditional settings: quality standards and guidance for program evaluation","volume":"49","author":"Postema","year":"2000","journal-title":"MMWR Recommend Rep Morb Mort Week Rep"},{"key":"10.1016\/j.vaccine.2018.11.043_b0105","unstructured":"Centers for Disease control and Prevention. 2013 IISAR data participation rates; 2014."},{"key":"10.1016\/j.vaccine.2018.11.043_b0110","unstructured":"Nebraska Department of Health and Human Services D of PH. Statues Relating to Pharmacy Practice Act; 2014."},{"key":"10.1016\/j.vaccine.2018.11.043_b0115","unstructured":"Iowa Department of Public Health. 2014 Iowa Immunization Program Annual Report; 2014."},{"key":"10.1016\/j.vaccine.2018.11.043_b0120","doi-asserted-by":"crossref","first-page":"459","DOI":"10.4140\/TCP.n.2015.459","article-title":"The impact of pharmacist interventions on herpes zoster vaccination rates","volume":"30","author":"Eid","year":"2015","journal-title":"Consult Pharm"},{"key":"10.1016\/j.vaccine.2018.11.043_b0125","unstructured":"American Pharmacist Association. Pharmacist Administered Vaccines. 2013. https:\/\/www.pharmacist.com\/sites\/default\/files\/PharmacistIZAuthority.pdf"},{"key":"10.1016\/j.vaccine.2018.11.043_b0130","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1016\/j.vaccine.2011.02.056","article-title":"Voluntary reporting of employee influenza vaccination rates by acute care hospitals in Iowa: the impact of a four year provider-based statewide performance improvement project","volume":"29","author":"Helms","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.11.043_b0135","doi-asserted-by":"crossref","unstructured":"National Vaccine Advisory Committee. Strategies to achieve the Healthy People 2020 annual influenza vaccine coverage goal for health-care personnel: Recommendations from the National Vaccine Advisory Committee. Public Health Reports 2013;128:7\u201325.","DOI":"10.1177\/003335491312800103"},{"key":"10.1016\/j.vaccine.2018.11.043_b0140","unstructured":"National Center for Health Statistics. Health, United States, 2016: With Chartbook on Long-term Trends in Health. Hyattsville, MD; 2017: 2017."},{"issue":"8","key":"10.1016\/j.vaccine.2018.11.043_b0145","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.clinthera.2017.07.004","article-title":"Impact of pharmacist immunization authority on seasonal influenza immunization rates across states","volume":"39","author":"Drozd","year":"2017","journal-title":"Clin Ther"},{"key":"10.1016\/j.vaccine.2018.11.043_b0150","unstructured":"Centers for Disease Control and Prevention. Shingles Surveillance. vol. 159; 2015."},{"key":"10.1016\/j.vaccine.2018.11.043_b0155","unstructured":"American Lung Association. Who Pneu\u202f?: A Pneumococcal Pneumonia Awareness Campaign 2015:1\u20135. http:\/\/www.lung.org\/about-us\/media\/top-stories\/who-pneu.html [accessed December 7, 2017]."},{"key":"10.1016\/j.vaccine.2018.11.043_b0160","unstructured":"GlaxoSmithKline. GSK statement on pneumococcal vaccine pricing 2017:7\u20139. http:\/\/www.gsk.com\/en-gb\/media\/resource-centre\/vaccines\/."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18315664?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18315664?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T17:07:55Z","timestamp":1572973675000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18315664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0264410X18315664"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.11.043","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of implementing a technology platform in community pharmacies to increase adult immunizations rates","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.11.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}